The epilepsy device market share has witnessed significant growth in recent years, driven by advancements in technology and increasing awareness about the condition. Epilepsy is a neurological disorder characterized by recurrent seizures, which can significantly impact an individual's quality of life. However, with the development of innovative devices, patients now have access to better management and control over their seizures.

Get Free PDF Sample Report: https://www.snsinsider.com/sample-request/2655

One of the key factors driving the growth of the epilepsy device market is the rising prevalence of epilepsy worldwide. According to the World Health Organization (WHO), around 50 million people globally are affected by epilepsy, making it one of the most common neurological disorders. This growing patient pool has created a demand for effective treatment options, leading to increased investments in research and development for epilepsy devices.

Technological advancements have played a crucial role in shaping the epilepsy device market. Devices such as implantable neurostimulators, responsive neurostimulation systems, and wearable seizure detection devices have revolutionized epilepsy management. These devices work by detecting abnormal brain activity or providing electrical stimulation to prevent As a result, individuals with epilepsy now have access to more personalized and innovative solutions for managing their condition.

KEY MARKET SEGMENTS

by End User

• Hospitals
• Neurology Centers
• Others

by Product Type

• Wearable Devices
• Conventional Devices
• Implantable Devices

by Technology

• Vagus Nerve Stimulation
• Responsive Neurostimulation
• Deep Brain Stimulation
• Accelerometry

by Epilepsy Detection & Prediction Devices

• Electroencephalogram
• Intracranial EEG
• Surface Electromyography
• Electrodermal Activity
• Electrocardiography
• Video Detection Systems
• Implanted Advisory Systems
• Others

Major Players Listed in the Report are as Follows:

Boston Scientific Corporation, Koninklijke Philips N.V, Compumedics Ltd., Cerbomed GmbH, Neuropace Inc., Medtronic Plc., Nihon Kohden Corporation, St. Jude Medical, Inc., Natus Medical Incorporated, Medpage Ltd, Liva Nova, MC10, Empatica Inc. and others

About US:

SNS Insider has been a leader in data and analytics globally with its authentic consumer and market insights. The trust of our clients and business partners has always been at the center of who we are as a company. We are a business that leads the industry in innovation, and to support the success of our clients, our highly skilled engineers, consultants, and data scientists have consistently pushed the limits of the industry with innovative methodology and measuring technologies.

We assist our clients to anticipate industrial, economic, and consumer trends to drive disruptive change by fusing global experience with local information from experts throughout the world. We bring context to strategic and tactical data by bridging approaches based on data science and field research, assisting you in addressing your most pressing problems and spotting possibilities.

Contact Us:

Akash Anand – Head of Business Development & Strategy,

info@snsinsider.com,

Phone: +1-415-230-0044 (US) | +91-7798602273 (IND)